The role of fibroblast growth factor 23 vs. parathyroid hormone in hypophosphatemia in long-term kidney transplantation

Bone ◽  
2011 ◽  
Vol 48 ◽  
pp. S148-S149
Author(s):  
S. Disthabanchong⁎ ◽  
S. Sirilak ◽  
V. Sumethkul ◽  
A. Ingsathit ◽  
S. Kantachuvesiri ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Parathyroid Hormone ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Fibroblast Growth Factor 23 ◽  
Fibroblast Growth

scholarly journals FIBROBLAST GROWTH FACTOR 23 IN LONG-TERM KIDNEY TRANSPLANTATION

2010 ◽  
Vol 90 ◽  
pp. 916
Author(s):  
S. Sirilak ◽  
W. Stitchantrakul ◽  
V. SumethKul ◽  
S. Kantachuvesiri ◽  
A. Ingsathit ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Fibroblast Growth Factor 23 ◽  
Fibroblast Growth

scholarly journals Parathyroid hormone or fibroblast growth factor 23? Which one is the main determinant of the hypophosphatemia after kidney transplantation?

2018 ◽  
Vol 8 (2) ◽  
pp. 86-90 ◽  
Author(s):  
Seyed Sadroddin Rasi Hashemi ◽  
Zahra Navarbaf ◽  
Amir Ghorbanihaghjo ◽  
Morteza Ghojazadeh ◽  
Jalal Etemadi ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Parathyroid Hormone ◽  
Renal Transplantation ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Mineral Metabolism ◽  
Fibroblast Growth Factor 23 ◽  
Fibroblast Growth ◽  
Kidney Transplant Recipients ◽  
Endstage Renal Disease

Introduction: Kidney transplantation restores many of the disorders accompanying endstage renal disease (ESRD). However, hypophosphatemia is common complication after renal transplantation. High levels of fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) are two suspected factors determining the hypophosphatemia after kidney transplantation. Objectives: This observational prospective study was carried out to clarify the role of mentioned factors in hypophosphatemia after kidney transplantation. Patients and Methods: Living donor kidney transplant recipients which admitted to the ward of the renal transplantation, enrolled to the study. Parameters of bone and mineral metabolism including FGF23 and intact PTH levels were assessed. Results: High FGF23 level before transplantation was related to lower phosphate levels at 3rd month after transplantation. PTH levels showed no relationship with hypophosphatemia after kidney transplantation. Conclusion: High levels of FGF23 in ESRD patients undergoing kidney transplantation is an important determinant of hypophosphatemia in long-term follow up.

Role of Fibroblast Growth Factor 23 (FGF23) in the Metabolism of Phosphorus and Calcium Immediately After Kidney Transplantation

2012 ◽  
Vol 44 (9) ◽  
pp. 2551-2554 ◽  
Author(s):  
A.I. Sánchez Fructuoso ◽  
M.L. Maestro ◽  
N. Calvo ◽  
V. De La Orden ◽  
I. Pérez Flores ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Fibroblast Growth Factor 23 ◽  
Fibroblast Growth

The role of fibroblast growth factor-23 in left atrial volume

2013 ◽  
Vol 165 (5) ◽  
pp. e21 ◽  
Author(s):  
Supawat Ratanapo ◽  
Wonngarm Kittanamongkolchai ◽  
Narat Srivali ◽  
Saeed Ahmed ◽  
Wisit Cheungpasitporn ◽  
...  
Keyword(s):  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Left Atrial ◽  
Fibroblast Growth Factor 23 ◽  
Left Atrial Volume ◽  
Fibroblast Growth ◽  
Atrial Volume

scholarly journals Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport

2016 ◽  
Vol 291 (36) ◽  
pp. 18632-18642 ◽  
Author(s):  
W. Bruce Sneddon ◽  
Giovanni W. Ruiz ◽  
Luciana I. Gallo ◽  
Kunhong Xiao ◽  
Qiangmin Zhang ◽  
...  
Keyword(s):  
Parathyroid Hormone ◽  
Growth Factor ◽  
Signaling Pathways ◽  
Fibroblast Growth Factor ◽  
Fibroblast Growth Factor 23 ◽  
Phosphate Transport ◽  
Fibroblast Growth
Sign in / Sign up

Export Citation Format

Share Document